Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026
April 23, 2026
Calycia Bioscience was awarded the People’s Choice Award at the 2026 Altitude Labs Demo Day. CaLycia is developing engineered macrophage therapies that hone in on solid tumors and alleviate immune suppression, unlocking a broader immune response against some of the hardest targets in oncology. BioUtah congratulates Daniel Greiner and the Calycia Bioscience team!
Recent News
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
- Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology
